Compile Data Set for Download or QSAR
maximum 50k data
Found 225 with Last Name = 'mccarthy' and Initial = 'td'
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM410295(US10370388, Compound Angiotensin)
Affinity DataKi:  0.898nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM50236697(5-L-isoleucineangiotensin II | 5-isoleucine-angiot...)
Affinity DataKi:  0.898nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM318822(US10370388, Compound Losartin | US9624243, Losarti...)
Affinity DataKi:  5.5nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM318822(US10370388, Compound Losartin | US9624243, Losarti...)
Affinity DataKi:  5.5nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM395229(US10308628, Compound 1)
Affinity DataKi:  7nMAssay Description:15 μL of [125I]CGP 42112A, at a final concentration of 0.05 nM was added to wells of assay plate.Membranes were dispersed using a 21 gauge needl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM395230(US10308628, Compound 2)
Affinity DataKi:  9nMAssay Description:15 μL of [125I]CGP 42112A, at a final concentration of 0.05 nM was added to wells of assay plate.Membranes were dispersed using a 21 gauge needl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM395233(US10308628, Compound 5)
Affinity DataKi:  9nMAssay Description:15 μL of [125I]CGP 42112A, at a final concentration of 0.05 nM was added to wells of assay plate.Membranes were dispersed using a 21 gauge needl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM395232(US10308628, Compound 4)
Affinity DataKi:  15nMAssay Description:15 μL of [125I]CGP 42112A, at a final concentration of 0.05 nM was added to wells of assay plate.Membranes were dispersed using a 21 gauge needl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM395231(US10308628, Compound 3)
Affinity DataKi:  17nMAssay Description:15 μL of [125I]CGP 42112A, at a final concentration of 0.05 nM was added to wells of assay plate.Membranes were dispersed using a 21 gauge needl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM395238(US10308628, Compound 10)
Affinity DataKi:  21nMAssay Description:15 μL of [125I]CGP 42112A, at a final concentration of 0.05 nM was added to wells of assay plate.Membranes were dispersed using a 21 gauge needl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM395237(US10308628, Compound 9)
Affinity DataKi:  23nMAssay Description:15 μL of [125I]CGP 42112A, at a final concentration of 0.05 nM was added to wells of assay plate.Membranes were dispersed using a 21 gauge needl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM395234(US10308628, Compound 6)
Affinity DataKi:  26nMAssay Description:15 μL of [125I]CGP 42112A, at a final concentration of 0.05 nM was added to wells of assay plate.Membranes were dispersed using a 21 gauge needl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM395236(US10308628, Compound 8)
Affinity DataKi:  30nMAssay Description:15 μL of [125I]CGP 42112A, at a final concentration of 0.05 nM was added to wells of assay plate.Membranes were dispersed using a 21 gauge needl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM395235(US10308628, Compound 7)
Affinity DataKi:  50nMAssay Description:15 μL of [125I]CGP 42112A, at a final concentration of 0.05 nM was added to wells of assay plate.Membranes were dispersed using a 21 gauge needl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM410295(US10370388, Compound Angiotensin)
Affinity DataIC50:  1.80nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM50236697(5-L-isoleucineangiotensin II | 5-isoleucine-angiot...)
Affinity DataIC50:  1.80nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM318817(1-(2S,4S)-44(3-(4-fluorophenyl)propyl)(methyl)amin...)
Affinity DataIC50:  3.52nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM410289(US10370388, Compound 138)
Affinity DataIC50:  3.52nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM263926(US9714224, 40 | US9714224, 41)
Affinity DataIC50:  10.9nMAssay Description:120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. The binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM318822(US10370388, Compound Losartin | US9624243, Losarti...)
Affinity DataIC50:  11nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM318822(US10370388, Compound Losartin | US9624243, Losarti...)
Affinity DataIC50:  11nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM318782((2S,4S)-1-(2,2-diphenylacetyl)-4-((3-(4-fluorophen...)
Affinity DataIC50:  12nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM318782((2S,4S)-1-(2,2-diphenylacetyl)-4-((3-(4-fluorophen...)
Affinity DataIC50:  12nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM318800((2S,4S)-N-(N,N-dimethylsulfamoyl)-1-(2,2-diphenyla...)
Affinity DataIC50:  17.1nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM410270(US10370388, Compound 114)
Affinity DataIC50:  17.1nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM318790((2S,4S)-1-(2,2-diphenylacetyl)-4-(5-phenyl-1H-1,2,...)
Affinity DataIC50:  18nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM318790((2S,4S)-1-(2,2-diphenylacetyl)-4-(5-phenyl-1H-1,2,...)
Affinity DataIC50:  18nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM318810((2S,4S)-1-(2,2-diphenylacetyl)-4-((2-fluorophenoxy...)
Affinity DataIC50:  20.5nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM318810((2S,4S)-1-(2,2-diphenylacetyl)-4-((2-fluorophenoxy...)
Affinity DataIC50:  20.5nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM263925(US9714224, 34)
Affinity DataIC50:  33.5nMAssay Description:120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. The binding ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM318438((2S,4R)-4-((4,4-dimethylpent-2-yn-1-yl)(methyl)ami...)
Affinity DataIC50:  33.9nMAssay Description:120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs.The binding r...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM261619((S)-4-(1-benzyl-3-methyl-1H-pyrazol-5-yl)-1-(2,2-d...)
Affinity DataIC50:  40.3nMAssay Description:120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs.The binding r...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM318780((3R,3′S,5′S)-1-(2,2-diphenylacetyl)-3-...)
Affinity DataIC50:  43.6nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM410246(US10370388, Compound 87)
Affinity DataIC50:  43.6nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM318761( (2S,4S)-4-(3-benzylpiperidin-1-yl)-1-(2,2-dipheny...)
Affinity DataIC50:  43.9nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM318761( (2S,4S)-4-(3-benzylpiperidin-1-yl)-1-(2,2-dipheny...)
Affinity DataIC50:  43.9nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM318774( (2R,4R)-4-(2-benzylpiperidin-1-yl)-1-(2,2-dipheny...)
Affinity DataIC50:  49.1nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM318773( (2S,4S)-4-(2-benzylpiperidin-1-yl)-1-(2,2-dipheny...)
Affinity DataIC50:  49.1nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM410222(US10370388, Compound 51)
Affinity DataIC50:  50.3nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM318760(US10370388, Compound 50 | US9624243, 51)
Affinity DataIC50:  50.3nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM318747(4-(benzyloxy)-1-(2,2-diphenylacetyl)indoline-2-car...)
Affinity DataIC50:  54.5nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM410208(US10370388, Compound 15)
Affinity DataIC50:  54.5nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM318435(((2S,4R)-1-(2,2-diphenylacetyl)-4-((3-(4-fluorophe...)
Affinity DataIC50:  55.9nMAssay Description:120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs.The binding r...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM318806((2S,4S)-4-((benzylthio)methyl)-1-(2,2-diphenylacet...)
Affinity DataIC50:  57.7nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM318806((2S,4S)-4-((benzylthio)methyl)-1-(2,2-diphenylacet...)
Affinity DataIC50:  57.7nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM318758((2S,4S)-1-(2,2-diphenylacetyl)-4-((R)-3-phenylpipe...)
Affinity DataIC50:  58.8nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM318758((2S,4S)-1-(2,2-diphenylacetyl)-4-((R)-3-phenylpipe...)
Affinity DataIC50:  58.8nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM318750((2S,4S)-1-(2,2-diphenylacetyl)-4-(methyl(3-phenylp...)
Affinity DataIC50:  62.1nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM318750((2S,4S)-1-(2,2-diphenylacetyl)-4-(methyl(3-phenylp...)
Affinity DataIC50:  62.1nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetType-2 angiotensin II receptor(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM410271(US10370388, Compound 52)
Affinity DataIC50:  63.2nMAssay Description: 120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs. ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 225 total ) | Next | Last >>
Jump to: